WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
U.S. moon lander Peregrine completes reChina's satellite launch suffers abnormalityTiger Woods hints at an end to bitter PGAChina's newGuideline cleans up pollutantsHumanoid robots make public debut in BeijingAI tech helps in early detection of pancreatic cancerMonster Georgia father is sentenced to 50 years in prison for poisoning his 18Pic story of dancing couple in China's XinjiangKobe Bryant's widow gifts sneakers from her late husband's Nike line to LA Dodgers as All